Organogenesis (NASDAQ:ORGO – Get Free Report) had its price objective hoisted by research analysts at BTIG Research from $4.00 to $6.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price objective indicates a potential upside of 51.13% from the stock’s previous close. […]
Thompson Siegel & Walmsley LLC acquired a new stake in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) in the second quarter, Holdings Channel.com reports. The fund acquired 118,952 shares of the company’s stock, valued at approximately $395,000. Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. […]
Organogenesis (NASDAQ:ORGO – Free Report) had its target price hoisted by Morgan Stanley from $3.00 to $3.50 in a research report sent to investors on Tuesday morning, Benzinga reports. They currently have an equal weight rating on the stock. Separately, BTIG Research reduced their target price on Organogenesis from $10.00 to $4.00 and set a […]
Another Great Vacation Ownership available from Buy & Sell TimesharesName of Resort:HGVC Points - Borgo Alle Vigne Buyer’s First Year of Usage:2024UsageAnnual Unit/Week Info: Float Unit 2 bedroom Pl | RealGeni.com
By Stephen Nakrosis Organogenesis Holdings shares traded near a three-month low shortly before the end of Thursday's regular session, a day after the company.